MacroGenics, Inc. (MGNX) is a publicly traded Healthcare sector company. As of August 19, 2026, MGNX trades at $4.09 with a market cap of $258.62M and a P/E ratio of -18.61. MGNX moved +0.74% today. Year to date, MGNX is +154.04%; over the trailing twelve months it is +169.08%. Its 52-week range spans $0.99 to $5.08. Analyst consensus is buy with an average price target of $6.50. Rallies surfaces MGNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MacroGenics, Inc. (MGNX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MGNX moved +0.74% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $4.09 |
| Market Cap | $258.62M |
| P/E Ratio | -18.61 |
| EPS | $-0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.08 |
| 52-Week Low | $0.99 |
| Volume | 370.58K |
| Avg Volume | 0 |
| Revenue (TTM) | $167.67M |
| Net Income | $-14.59M |
| Gross Margin | 0.00% |
2 analysts cover MGNX: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.50.